Page 2 - Ccxp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ccxp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ccxp Today - Breaking & Trending Today

Acurx Pharma Falls 25%

Shares of late-stage biopharma company Acurx Pharmaceuticals, Inc. (ACXP) are falling more than 25 percent on Wednesday morning trade, despite reporting positive comparative data from Ibezapolstat from Phase 2b trial in CDI patients. ....

Federal Reserve , View More , Stock Alert , Acurx Pharmaceuticals ,

Acurx Pharma Discontinues Phase 2b Trial For Ibezapolstat To Treat C. Difficile Infection

Biopharmaceutical company Acurx Pharmaceuticals, Inc. (ACXP) announced Monday that the Company has discontinued the Phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat, for the treatment of patients with Clostridioides difficile infection (CDI) due to success. ....

Data Monitoring Committee , Acurx Pharmaceuticals Inc , Acurx Pharmaceuticals , Independent Data Monitoring Committee , Fast Track Designated , Acurx Pharma , Clostridioides Difficile Infection ,